Editorial: the impact of the placebo effect in Crohn's disease

Affiliations

¹ Department of Internal Medicine, University of Manitoba IBD Clinical and Research Centre, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Editorial

C N Bernstein. Aliment Pharmacol Ther. 2017 Jun.

. 2017 Jun;45(11):1471-1472.

doi: 10.1111/apt.14036.

¹ Department of Internal Medicine, University of Manitoba IBD Clinical and Research Centre, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

No abstract available

Comment in

Editorial: the impact of the placebo effect in Crohn's disease - author's reply.
Jairath V, Feagan BG. Jairath V, et al. Aliment Pharmacol Ther. 2017 Jun;45(11):1472. doi: 10.1111/apt.14074. Aliment Pharmacol Ther. 2017. PMID: 28474832 No abstract available.

Systematic review with meta-analysis: placebo rates in induction and maintenance trials of Crohn's disease.
Jairath V, Zou G, Parker CE, MacDonald JK, Mosli MH, AlAmeel T, Al Beshir M, AlMadi M, Al-Taweel T, Atkinson NS, Biswas S, Chapman TP, Dulai PS, Glaire MA, Hoekman D, Kherad O, Koutsoumpas A, Minas E, Restellini S, Samaan MA, Khanna R, Levesque BG, D'Haens G, Sandborn WJ, Feagan BG. Jairath V, et al. Aliment Pharmacol Ther. 2017 Apr;45(8):1021-1042. doi: 10.1111/apt.13973. Epub 2017 Feb 5. Aliment Pharmacol Ther. 2017. PMID: 28164348